
Intellia Therapeutics, Inc.
USD13.02
-0.11 (-0.84%)
CEO
John Leonard
IPO Date
2016-05-06
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$13.09
Prev. Close
$13.13
Day Low
$12.47
Day High
$13.09
52W Low
$7.31
52W High
$28.25
Market Cap
$1.46B
Volume
3.02M
| 12 May 2026 |
| Wedbush |
| Neutral |
| Neutral |
| maintain |
| 28 Apr 2026 | Citizens | Market Outperform | Market Outperform | maintain |
| 28 Apr 2026 | Canaccord Genuity | Buy | Buy | maintain |
| 28 Apr 2026 | Goldman Sachs | Sell | Sell | maintain |
| 28 Apr 2026 | Morgan Stanley | Equal Weight | Equal Weight | maintain |
| 27 Apr 2026 | Baird | Neutral | Neutral | maintain |
| 27 Apr 2026 | Chardan Capital | Buy | Buy | maintain |